Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Choosing the right emergency fund size depends on income, expenses, and job stability. This guide compares 3, 6, and 12 months to help you decide.
24,365 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
The U.S. shipbuilding industry is looming a 250,000-worker gap over the next decade, even as the Trump administration...
AFC Gamma investors are watching the Q1 2026 earnings call closely. This guide breaks down what to expect, how to rea...
Pfizer's stock has lagged since 2021, but the story isn’t over. This guide breaks down why pfizer stock: still priced...
Trump heads Beijing high-stakes summit as markets watch for any change in US-China policy on crypto, potentially resh...
Canopy Growth sits at the center of sharp investor debate. This article maps three plausible paths for the stock over...
As the debate over earnings reporting evolves, good quarterly earnings behavior becomes a competitive edge. This guid...
In 2026, MSTR stock has outpaced Bitcoin even as Strategy’s funding stack tests the durability of its preferreds. Inv...
The day brought a notable jump in the QBTS stock as headlines pointed to potential funding. This guide breaks down wh...
Shark Tank star Kevin O’Leary renews a controversial stance on work-life balance, saying employees who seek rigid hou...
Visa now dominates crypto-card payments, handling the vast majority of activity as stablecoins aimed to bypass legacy...
A new study finds Republican lawmakers are increasingly tilting their portfolios toward Bitcoin and related crypto as...